Netherlands Neurology Devices Market Analysis Report [2022-30]

Netherlands Neurology Devices Market Analysis

$ 3999

The Netherland Neurology Devices Market size was valued at $33 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of xx% from 2022 to 2030 and will reach $xx Mn in 2030. The market is expanding as a result of the creation of cutting-edge neurology devices such as portable EEG devices and neurostimulation devices. Neurological conditions like epilepsy, Parkinson's disease, and Alzheimer's disease are becoming more common. In order to diagnose, treat, and manage these conditions, neurology devices are in high demand. The market is segmented by product type and by the end user. Some key players in this market include Medtronic, Stryker, Abbott Laboratories, B. Braun Melsungen AG, Qiagen, Abbott Laboratories, and GE Healthcare.

ID: IN10NLMD012 CATEGORY: Medical Devices GEOGRAPHY: Netherlands AUTHOR: Jigyasu Bhandari

Buy Now

Netherlands Neurology DevicesMarket Executive Analysis

The Netherlands Neurology Devices Market is at around $33 Mn in 2022 and is projected to reach $xx Mn in 2030, exhibiting a CAGR of xx% during the forecast period. The Netherlands spent 10.5% of its GDP on health care, and 81% of that amount was covered by a mixture of copayments (11%), general taxation (22%), designated payroll taxes paid by employers (46%), and general taxation (22%). The Netherlands spent $5.33 Mn per capita on healthcare in 2019. The Netherlands' health spending per capita rose from $3.02 Mn in 2012 to $5.33 Mn in 2019, expanding at a compound annual rate of 5.64%.

In the Netherlands, neurology devices are significant for the diagnosis, management, and therapy of neurological illnesses and are crucial tools for medical professionals and researchers. Devices for measuring electrical activity in the brain and nerves, such as electromyography (EMG) and electroencephalography (EEG) devices, are used in neurology to identify neurological illnesses. Neurology devices are used to treat neurological problems i.e., Deep Brain Stimulation (DBS) devices are used to treat Parkinson's disease and epilepsy. Neuroprosthetic devices for patients with paralysis or amputations are examples of neurology devices used for the rehabilitation of neurological illnesses. Magnetic Resonance Imaging (MRI) instruments, which are used to analyze the anatomy and function of the brain, are among the neurology devices utilized in research. Patients who are not responding to pharmacological therapy or other forms of medication typically use sacral nerve stimulation devices. A tiny device that can provide electrical impulses to the targeted sacral nerves in the lower back is used to carry out the procedure.

netherlands neurology devices market analysis

Market Dynamics

Market Growth Drivers

In the Netherlands, neurological conditions like epilepsy, Parkinson's disease, and Alzheimer's disease are becoming more common. In order to diagnose, treat, and manage these conditions, neurology devices are in high demand. The Dutch government encourages innovation in the healthcare industry, encouraging the adoption of cutting-edge medical technologies, and investing in research and development. This is fostering a positive regulatory environment for neurology devices in the nation. The market is expanding as a result of the creation of cutting-edge neurology devices such as portable EEG devices and neurostimulation devices. As a result of their improved accuracy, mobility, and usability, these technologies are becoming more widely used in the healthcare industry. The Netherlands has a highly developed healthcare system and significant healthcare spending. This is significantly promoting the creation and uptake of neurological devices in the Netherlands.

Market Restraints

The competitive market for neurology devices in the Netherlands is fragmented. Market participants are engaged in research and development (R&D) for the creation of sophisticated stimulation and neuromodulation techniques with minimally invasive treatments that are more favored by patients. Neurology device reimbursement can be difficult, as not all devices are covered by health insurance policies. Accessing the tools they require may become challenging for patients and healthcare professionals as a result. In the Netherlands, the regulatory environment for neurology devices, notably neurological devices, is strictly regulated, and compliance with laws can be difficult and time-consuming. This may raise entrance hurdles for cutting-edge and novel devices.

Competitive Landscape

Key Players

B. Braun Melsungen AG
Stryker
Medtronic
Boston Scientific
Abbott Laboratories
GE Healthcare
Qiagen

Notable Recent Deals

2020: The Swiss company MedTech Innovator's acquisition of the Netherlands company medPhoton in 2020 is one significant acquisition in the Netherlands neurology devices market. A company by the name of medPhoton designs and produces tools for image-guided radiotherapy and radiosurgery.

Healthcare Policies and Regulatory Landscape

In the Netherlands, the healthcare policies and regulatory environment for neurology devices are well-established and strictly regulated. To get their items on the market, manufacturers must traverse a variety of laws and rules and make sure their products uphold strict requirements for effectiveness, quality, and safety. Neurology devices cannot be marketed or supplied in the Netherlands until they have been registered with and authorized by the Dutch Medicines Evaluation Board (MEB). Reimbursement guidelines established by the Dutch Healthcare Authority and the Health Insurance Act apply to neurology devices. Usually, only devices that have been found to be efficient and affordable are reimbursed. The Dutch government has set up a post-market surveillance system to keep an eye on the security and efficiency of medical devices, particularly those used in neurology after they have been authorized and put on the market. The development and commercialization of innovative neurological devices are impacted by laws and regulations in the Netherlands that safeguard intellectual property, including trademarks and patents.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Neurology Device Market Segmentation

The Neurology Device Market is segmented as mentioned below:

By Product Type (Revenue, USD Billion):

Neurostimulation
?Spinal Cord Stimulation Devices
Deep Brain Stimulation Devices
Sacral Nerve Stimulation
Vagus Nerve Stimulation
Gastric Electric Stimulation
Interventional Neurology
- Aneurysm Coiling & Embolization
- Embolic Coils
- Flow Diversion Devices
- Liquid Embolic Agents
- Cerebral Balloon Angioplasty & Stenting
- Carotid Artery Stents
- Filter Devices
- Balloon Occlusion Devices
- Neurothrombectomy
- Clot Retriever
- Suction Aspiration Devices
- Snares
CSF Management
- CSF Shunts
- CSF Drainage
Neurosurgery Devices
- Ultrasonic Aspirators
- Stereotactic Systems
- Neuroendoscopes
- Aneurysm Clips

By End User (Revenue, USD Billion):

??Hospitals and Clinics
Specialty Centres
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.